Gastroenterology Clinics of North America 1994: Vol 23 Index

21 Pages·1994·4.7 MB·English

CUMULATIVE INDEX 1994
Volume 23
March GASTROINTESTINAL BLEEDING II, pages 1-188
June POSTSURGICAL SYNDROMES, pages 189-428
September VIRAL HEPATITIS, pages 429-620
December PEDIATRIC GASTROENTEROLOGY, PART I, pages 621-788
Note: Page numbers of issue and article titles are in boldface type.
Absorption, nutrient, in short bowel diagnosis of, 191, 287-289
syndrome, strategies for, 405-408 pathophysiology of, 282-286
of caloric foods, disorders of, after gas- treatment of, 289-291
tric surgery, 228-241 Allergy, to cow’s-milk protein, bleeding in,
Acarbose, for dumping syndrome, 267 100-101
Accommodation response, gastric, 200-201 Alpha-fetoprotein, measurement of, in
Achalasia, esophageal, dysphagia in, 220 hepatocellular carcinoma screening,
Acquired immunodeficiency syndrome. 574-575
See Human immunodeficiency virus Aminoaciduria, with hereditary pancreati-
infection. tis, 747
Acrodermatitis, papular, in hepatitis B, 757 Amniotic fluid, ingestion of, 658-659
Actin, antibodies to, in autoimmune Amoxicillin, in peptic ulcer disease, in
hepatitis, 548 pediatric patients, 719-720
Acyclovir, in hepatitis B, 584 Ampicillin, in peptic ulcer disease, in
pediatric patients, 108, 719
in hepatitis C, 610
Amylase, in hereditary pancreatitis, 745
Adenine arabinoside, in hepatitis B, 584
Amyloidosis, bleeding in, 35
Adenocarcinoma, small intestinal, bleeding
Anemia, after bariatric surgery, 366
from, 72 after gastric surgery, 245-249
Adenomatous polyposis syndromes, Angelchik prosthesis insertion, results of,
bleeding in, 111-112 377-378
Adenovirus infection, hepatitis in, in Angina pectoris, vs. heartburn, 220
pediatric patients, 764 Angiodysplasia, colonic, 2-10
Afferent loop syndromes, postoperative, small intestinal, 68-71, 75-76
evaluation of, 224-225 Angiography. See also Visceral
Aganglionosis coli, bleeding in, 99-100 arteriography.
AIDS. See Human immunodeficiency virus in colonic varices, 24
infection. in diverticulosis, 14-15, 17-18
Alanine aminotransferase, in hepatitis B, in small intestinal bleeding, 78-80, 85
588 in vascular ectasia, 8-9, 69-70
in hepatitis E, 539-540 Anorectal manometry, in defecation
Alcoholic liver disease, hepatocellular disorders, in pediatric patients, 630
carcinoma and, 573 Antacids, in alkaline reflux gastritis, 289
Alkaline Bernstein test, in alkaline reflux in peptic ulcer disease, in pediatric pa-
gastritis, 288-289 tients, 716
Alkaline reflux gastritis, postoperative, Antibiotics, Clostridium difficile infection
281-294 related to, in pediatric patients,
clinical presentation of, 286-287 639-640
770 CUMULATIVE INDEX 1994
Antibiotics (Continued) colonic, 2-10
in peptic ulcer disease, in pediatric pa- small intestinal, 76
tients, 718-720 Arthritis-dermatitis syndrome, after
Antibodies, in autoimmune hepatitis, bariatric surgery, 356-357
553-554, 556, 560-561 Asian Americans, hepatitis B in. See under
cryptogenic, 551 Hepatitis B.
type 1, 548-549 Atony, gastric, in Roux syndrome. See
type 2, Roux stasis (limb) syndrome.
type 3, 551 Autoimmune hepatitis, 547-566
in viral hepatitis. See also under specific cryptogenic, 551
virus. diagnosis of, 555-558
determination of, 459 exacerbation of, interferon in, 589-590
Antibody capture test, in hepatitis false viral markers in, 559-560
diagnosis, 459 hepatitis A in, 553
Antigens, of hepatitis viruses. See also hepatitis B in, 552-553, 555, 557-558, 560
under specific virus. hepatitis C in, 434, 549-561
determination of, 459-460 histology of, 538
Antinuclear antibodies, in autoimmune HIV infection in, 553
hepatitis, 548, 556 in pediatric patients, 764
Antireflux surgery, 371-389 treatment of, 558-561
complications of. See also Roux stasis type 1 (classic, lupoid), 548-549
(limb) syndrome. type 2, 549-550
dysphagia, 219-220, 379-382 type 3, 551
gastric functional abnormalities, 382- viral origin of, 552-555
384 vs. hepatitis C, 557
recurrent hernia, 384-385 vs. viral hepatitis, 560-561
recurrent reflux, 378-379 with high-titer autoantibodies, 561
reoperation for, 385-386 with low-titer autoantibodies, 560
patient selection for, 371-372 Azathioprine, in small intestine
repeated, 385-386 transplantation, 735
results of, 371-372 Azotorrhea, after gastric surgery, 229
Angelchik prosthesis insertion, 377-
378
Belsey Mark IV procedure, 372-373
Hill operation, 373-374 Bacterial overgrowth, after gastric surgery,
Nissen fundoplication, 219, 374-377 253-254
video-assisted, 386-387 in short bowel syndrome, 410
Antiviral agents, in hepatitis B, historical Balloon dilation, of esophagus, after
view of, 583-584 antireflux surgery, 381
Antral G-cell hyperfunction, recurrent Banding, gastric, in morbid obesity, 349
peptic ulcer and, 300-301 Bariatric surgery, 345-369
Antrectomy, gastric emptying after, 205, complications of, 350-367
314, 331 abdominal pain, 364
Antroduodenal motility, in pediatric anatomic effects, 353
patients, development of, 661-665 arthritis-dermatitis syndrome, 356-357
feeding effects on, 665 cholelithiasis, 353-354
preterm infants, 665-666 diarrhea, 355
Anus, stenosis of, in pediatric patients, 627 due to knowledge deficits, 352
Aortic stenosis, angiodysplasia in, 70-71 gastroesophageal reflux, 363
Aortoenteric fistula, bleeding in, 167-168, in gastric restrictive operations, 359-
170-172 367
Aphthous ulcers, in small intestine graft in malabsorptive operations, 354-358
rejection, 732-733 inadequate weight loss, 366-367
Apt-Downey test, in bleeding, in pediatric intestinal, 357-358
patients, 94 liver dysfunction, 358
Arterial embclism, mesenteric, 28 metabolic, 355-356
Arterial thrombosis, mesenteric, 28 neurologic, 366
Arteriography. See Angiography. nutritional, 365-366
Arteriovenous malformation, peptic ulcer disease, 362-363
arteriography of, 136 perioperative, 350-351
CUMULATIVE INDEX 1994 771
physiologic, 353 in angiodysplasia, colonic, 2-10
prosthesis erosion, 364-365 small intestinal, 68-71, 75-76
psychosocial influences on, 352 in congenital malformations, 95-98
urinary stones, 356 in Dieulafoy lesion, 33-34
vomiting, 359-362 in diversion colitis, 27
weight loss, 353 in diverticulosis, colonic, 1-20
stoma dilation after, 361-362 small intestinal, 31-32, 74-75
techniques for, 346-350 in endometriosis, 41-43
weight loss after, 244-245 in end-stage liver disease, 105
Barium enema, in defecation disorders, in in gastroesophageal reflux, 101-102
pediatric patients, 629 in hemolytic-uremic syndrome, 104-105
in occult bleeding, 62-63 in Henoch-Schénlein purpura, 34, 103-
in solitary rectal ulcer syndrome, 23 104
Barium studies, in bleeding, 124-125 in hereditary disorders, 109-112
in dysphagia, 216-217 in I lirschsprung’s-associated enterocoli-
in peptic ulcer disease, in pediatric pa- tis, 99-100
tients, 711-712 in infections. See Infections.
Behavioral modification, for defecation in inflammatory bowel disease, 108-109
disorders, in pediatric patients, in intestinal duplication, 95-96
633-634 in intussusception, 38-40, 102-103
Belch, inability to, after antireflux surgery, in lymphoid nodular hyperplasia, 102
382-384 in marathon running, 40-41
Belsey Mark IV procedure, results of, in Meckel’s diverticulum, 32-33, 73,
372-373 96-97
Bernstein test, alkaline, in alkaline reflux in mesenteric vascular insufficiency,
gastritis, 288-289 27-31
Bethanechol, in postgastrectomy in necrotizing enterocolitis, 98-99
in pediatric patients, 93-122
syndromes, 315-316, 338
in congenital malformations, 95-98
Bile acids, in alkaline reflux gastritis,
in early-childhood disorders, 98-105
285-286, 289-290
in hereditary disorders, 109-112
in vitamin E absorption, 694
in later-childhood disorders, 106-109
Biliopancreatic bypass, in morbid obesity,
in peptic ulcer disease, treatment of,
349-350
715-716
Billroth I procedure, complications of,
in spurious conditions, 94
dumping syndrome, 270
in peptic ulcer disease, 58, 106-107, 152-
gastric emptying alterations, 239, 332
153
weight loss, 242-243
recurrent, 297
Billroth II procedure, complications of, in polyposis, 109-112
alkaline reflux gastritis, 287 in portal colopathy, 24-25
gastric emptying alterations, 331 in radiation-induced injury, 25-26, 74
loop syndromes, 224-225 in solitary rectal ulcer syndrome, 21-24
pancreatic dysfunction, 236, 239 in spurious conditions, in pediatric pa-
weight loss, 242-243 tients, 94
conversion to Billroth I anastomosis, in in tumors, small intestinal, 71-72
dumping syndrome, 270 in ulceration, in solitary rectal ulcer syn-
Biofeedback training, for defecation drome, 21-24
disorders, in pediatric patients, 634 small intestinal, 36-38, 72-73
Biopsy, in peptic ulcer disease, in pediatric in varices. See Varices.
patients, 713 in vascular ectasia, 1-20
liver, in hepatitis B, 582-583 colonic, 2-10
Bishop-Coop ileostomy, in small intestine small intestinal, 68-71
transplantation, 731 in vascular lesions, small intestinal,
Bismuth compounds, in peptic ulcer dis- 75-76
ease, in pediatric patients, 108, in vascular malformation, 97-98
719-720 arteriography of, 136
Bleeding, colonic. See under Colon. occult, 59
drug-induced, small intestinal, 74 in vasculitis, 34-36
esophageal, 58, 101-102 small! intestinal, 74
evaluation of. See also specific disorder. in Zollinger-Ellison syndrome, small in-
small intestinal, 76-85 testinal, 73
772 CUMULATIVE INDEX 1994
Bleeding (Continued) after gastrectomy, 209-210
jejunal. See Jejunum. after vagotomy, 209-210
occult, 53-66 in parenteral nutrition, 409
radiology in. See Radiology. Cholera, in pediatric patients, 638-639,
reactivation of, for diagnostic studies, 643-645
131-132 Cholestasis, in pediatric patients, fat-
small intestinal. See under Small intes- soluble vitamins and, 673-705
tine. vitamin A, 674-682
traumatic, arteriography in, 135 vitamin D, 682-689
treatment of. See also specific disorder. vitamin E, 691-702
small intestinal, 86-88 vitamin K, 689-691
unusual causes of, 21-52 small intestine transplantation in, 730
Bloating, after antireflux surgery, 382-384 Cholestyramine, in short bowel syndrome,
Blood, viral transmission in, hepatitis B, 407
H2-443 Chronic idiopathic intestinal pseudo-
hepatitis C, 446-447, 449 obstruction syndrome, in pediatric
hepatitis delta, 450 patients, 627
Bone disease, after gastric surgery, 249-253 Churg-Strauss syndrome, bleeding in, 34
Branched DNA amplification, in viral Cimetidine, in peptic ulcer disease, in
hepatitis diagnosis, 489-490 pediatric patients, 107
Breast-feeding, blood ingestion in, 94 Cirrhosis, after bariatric surgery, 358
milk protein intolerance in, 100 epidemiology of, in Asian Americans,
Breath tests, in peptic ulcer disease, in 529-530
pediatric patients, 713-714 in hepatitis C, 445-446
Bypass enteritis, after bariatric surgery, Cisapride, in gastric emptying, in pediatric
357 patients, 661
in postgastrectomy syndromes, 316, 318-
320, 338
Clarithromycin, in peptic ulcer disease, in
Calcification, of pancreas, 745, 747 pediatric patients, 719
Calcium disorders, after gastric surgery, Cloning, of viral hepatitis genes, 483-484
251-252 Clostridium difficile infection, in pediatric
Caliciviridae, hepatitis E virus as, 542 patients, 639-640
Cancer, gastric, surgery for, reflux after, Clotting factors, measurement of, in
221-222 vitamin K status evaluation, 690
Carbohydrate malabsorption, after gastric Colectomy, in diverticulosis, 15
surgery, 229, 231 in vascular ectasia, 9-10, 18
Carcinoma, hepatocellular. See Colitis, diversion, 27
Hepatocellular carcinoma. fulminant, in pediatric patients, 109
Cardiac events, after bariatric surgery, 351 hemorrhagic, enterohemorrhagic Esche-
Carotenoids. See Vitamin A. richia coli in, 641-642
Catheterization, selective, in bleeding in cow’s-milk protein intolerance, 100-
therapy, vasopressin in, 139-143 101
Catheter-related disorders, in short bowel ischemic, 30-31
syndrome, 409 ulcerative, in pediatric patients, 108-109
Cecum, bleeding in, 134 Colon, absorption in, in short bowel
Chemiluminescence techniques, in viral syndrome, 407-408
hepatitis diagnosis, 486 bleeding in, after diversion, 27
Chemotherapy, hepatitis B reactivation in, evaluation of, 16-18
465 in cow’s-milk protein intolerance, 100-
in hepatocellular carcinoma, 575 101
Chimerism, in small intestine in Dieulafoy lesion, 33-34
transplantation, 739 in diverticulosis, 1-20
Cholecystectomy, after bariatric surgery, in endometriosis, 41-43
354 in Gardner’s syndrome, 111-112
gastrointestinal pacing after, 399-400 in hemolytic-uremic syndrome, 104-
Cholecystokinin, secretion of, after 105
vagotomy, 210 in Hirschsprung’s-associated enteroco-
Cholelithiasis, after bariatric surgery, litis, 99-100
353-354 in infections, 112
CUMULATIVE INDEX 1994 773
in inflammatory bowel disease, 108- Coxsackie A virus infection, hepatitis in, in
109 pediatric patients, 764
in intestinal duplication, 95-96 Crohn’s disease, bleeding in, 72-73
in intussusception, 38-40, 102-103 in pediatric patients, 108-109
in lymphoid nodular hyperplasia, 102 Cronkhite-Canada syndrome, bleeding in,
in marathon running, 40-41 110
in mesenteric vascular insufficiency, CRST syndrome, bleeding in, small
27-31 intestinal, 76
in necrotizing enterocolitis, 98-99 Cryoglobulinemia, bleeding in, 36
in polyposis, 109-112 Cryptogenic hepatitis, 551
in portal colopathy, 24-25 Cryptosporidium infection, in pediatric
in varices, 24-25, 137 patients, 642-643
in vascular ectasia, 2-10 Culture, of Helicobacter pylori, in pediatric
in vascular malformation, 97-98 patients, 713
in vasculitis, 34-36 “Currant jelly stool,” in intussusception,
occult, 53-66 102
radiologic management of. See Radiol- Cyclospora cayetanensis infection, in
ogy, in bleeding management. pediatric patients, 643
vasopressin therapy in, 139-143 Cytochrome mono-oxygenase, antibodies
interposition of, in small intestine resec- to, in autoimmune hepatitis, 550
tion, 413 Cytomegalovirus infection, hepatitis in, in
manometry of, in pediatric patients, 631 pediatric patients, 764
motility of, development of, 666-667
in HIV infection, 518-519
obstruction, after bariatric surgery, 358
Colonic transit time, in defecation
disorders, in pediatric patients, 630
Colonoscopy, in bleeding, 124-125 Defecation, disorders of. See also
in diverticulosis, 14, 17 Constipation; Diarrhea; Encopresis.
in portal colopathy, 25 classification of, 624-628
in vascular ectasia, 7-8 clinical presentation of, 624-628
occult, 63 mechanisms for, development of, 666—
Colorectal cancer, intussusception in, 39 667
occult bleeding in, 53 physiology of, 622-623
screening for, 59-62 Defecography, in pediatric patients, 630
testing for, 56 Delta hepatitis. See Hepatitis delta.
Compute tomography, in hereditary Dermatitis, after bariatric surgery, 356-357
pancreatitis, 745 Diarrhea, after bariatric surgery, 355
Congenital malformations, bleeding in,
after vagotomy, 272-275
95-98
in short bowel syndrome, management
Congo red test, in recurrent peptic ulcer,
of, 406-408
303-305
infectious, in pediatric patients, 637-654
Conjunctival impression cytology method,
Clostridium difficile in, 639-640
in vitamin A status evaluation, 681
Cryptosporidium in, 642-643
Constipation, in pediatric patients, 621-636
causes of, 625, 627 Cyclospora cayetanensis in, 643
defecation physiology and, 622-623 enterohemorrhagic Escherichia coli
definition, 621 in, 641-642
diagnosis of, 628-631 enterotoxigenic Escherichia coli in,
incidence, 621 647-648
treatment of, 631-634 epidemiology of, 637
Corticosteroids, after small intestine rotavirus in, 645-647
transplantation, 731 Shigella in, 648-649
in autoimmune hepatitis, 549 vaccines for, 643-649
in hepatitis B, 593-594 Vibrio cholerae in, 638-639, 643-645
in hepatitis C, 610 Dideoxyinosine, in hepatitis B, 584
in small intestine transplantation, 735 Diet, diverticulosis and, 10, 13
prenatal, in fetal motility development, for defecation disorders, in pediatric pa-
666 tients, 631-634
Cowden’s syndrome, bleeding in, 110 for diarrhea, after bariatric surgery, 355
Cow’s-milk protein intolerance, bleeding for dumping syndrome, 265-266
in, 100-101 occult blood testing and, 55
774 CUMULATIVE INDEX 1994
Dieulafoy lesion, 33-34 Electrolytes, loss of, in short bowel
radiologic management, 174 syndrome, 408
Distal onlay-reversed ileal graft, in Electromyography, in defecation disorders,
postvagotomy diarrhea, 275 in pediatric patients, 631
Diversion, colitis, 27 ELISA. See Enzyme-linked immunosorbent
Diverticula, arteriography of, 132-133 assay.
colonic, 10-18 Embolism, of mesenteric arteries, 28
anatomy of, 11-12 Embolization, in bleeding therapy, 143,
clinical features of, 14 146-147, 149-156
epidemiology of, 12-13 in Dieulafoy lesion, 174
evaluation of, 14-15 in hemobilia, 170, 173
pathophysiology of, 13 in portal hypertension, 162
treatment of, 15 in vascular ectasia, 9
jejunal, 74-75 Emptying, gastric. See Gastric emptying.
Meckel’s, 32-33, 73 Encopresis, in pediatric patients, 621-636
in pediatric patients, 96-97 causes of, 624-625
small intestinal, 31-32, 74-75 defecation physiology and, 622-623
Domperidone, in postgastrectomy definition, 621-623
syndromes, 320, 338 diagnosis of, 628-631
Dot blot hybridization, in viral hepatitis treatment of, 631-634
diagnosis, 485-486 Endometriosis, gastrointestinal bleeding in,
Dumping syndrome, 261-272 41-43
after gastric surgery, 244 Endoscopy. See also Colonoscopy.
clinical features of, 261-262 in alkaline reflux gastritis, 288
diagnosis of, 265 in peptic ulcer disease, in pediatric pa-
early, 262-264 tients, 712
incidence of, 264 in postoperative reflux, 222
late, 264 in recurrent peptic ulcer, 298-299
pathophysiology of, 262-264 of small intestine (enteroscopy), 80-84
prevention of, 264-265 in rejection monitoring, 732
treatment of, medical, 265-269 therapeutic, in peptic ulcer disease, in
pacing in, 396-398 pediatric patients, 715-716
surgical, 269-272 Enema. See also Barium enema.
Duodenum, bleeding in, in vascular for defecation disorders, in pediatric pa-
lesions, 75-76 tients, 634
motility of, in pediatric patients, develcp- Enteric nervous system, development of,
ment of, 661-665 656-658
feeding effects on, 665 Enteritis, bypass, after bariatric surgery,
preterm infants, 665-666 357
pacemaker of, 393 chronic ulcerative, 38
Duplication, intestinal, bleeding in, 95-96 Enteroclysis, in bleeding evaluation, 76-78
Dysentery, bacillary, in pediatric patients, Enterocolitis, Hirschsprung’s-associated,
648-649 99-100
Dysphagia, after antireflux surgery, necrotizing, 98-99
219-220, 379-382 radiation, 25-26
Hill operation, 373-374 Enterohemorrhagic Escherichia coli infec-
Nissen fundoplication, 219, 374 tion, in pediatric patients, 641-642
after gastrectomy, evaluation of, 216-220 Enteroscopy, 80-84
after vagotomy, evaluation of, 217-219 Enterotoxigenic Escherichia coli infection, in
in achalasia, 220 pediatric patients, 647-648
Enzyme-linked immunosorbent assay, in
hepatitis diagnosis, 458-459
hepatitis A, 458-459
Eating disorders, after small intestine hepatitis C, 467-468
transplantation, 738-739 Eosinophilia, in cow’s-milk protein
Ectasia, vascular. See Vascular ectasia. intolerance, 100-101
Education, patient, on bariatric surgery, Epstein-Barr virus infection, after small
352 intestine transplantation, 737-738
Efferent loop syndromes, postoperative, hepatitis in, in pediatric patients, 763-
evaluation of, 225 764
CUMULATIVE INDEX 1994 775
Erythromycin, in gastric emptying, in in pediatric patients, 728-729, 731, 735
pediatric patients, 661 Fluid management, in short bowel
in postgastrectomy syndromes, 320-322, syndrome, 408
335, 338 Fluoro-arabinofuranosyl-iodouracil, in
Escherichia coli infection, hemolytic-uremic hepatitis B, 595
syndrome in, 105 Folate deficiency, after gastric surgery, 246
in pediatric patients, enterohemorrhagic, Food, hepatitis A transmission in, 439
641-642 Food dye ingestion, versus bleeding, 94
enterotoxigenic, 647-648 Formulas, infant, after small intestine
Esophageal varices, arteriography of, 138 transplantation, 735
in pediatric patients, 105 Functional fecal retention, in pediatric
radiologic management of, 160, 162-163, patients, 627-628
166-167 Fundoplication, Nissen, results of, 219,
Esophagitis, occult bleeding in, 58 374-377
Esophagogastric junction reflux, after
vagotomy, 197
Esophagogastroduodenoscopy, in bleeding
evaluation, occult, 63 Gallbladder disorders, after bariatric
small intestinal, 81-83 surgery, 353-354
in peptic ulcer disease, in pediatric pa- after gastrectomy, 209-210
tients, 712 after vagotomy, 209-210, 274
Esophagus, achalasia of, dysphagia in, 220 in parenteral nutrition, 409
bleeding in, in gastroesophageal reflux, Gardner's syndrome, bleeding in, 111-112
101-102 Gas bloat, after antireflux surgery, 382-384
dilation of, after antireflux surgery, 381 Gastrectomy, syndromes after. See
luminal narrowing of, dysphagia in. See Postgastrectomy syndromes.
Dysphagia. Gastric acid, secretion of, measurement of,
motility of, development of, 659 in postgastrectomy syndromes, 190
reflux in. See Reflux, gastroesophageal. recurrent ulcer and, 295-297, 302-305
Essential mixed cryoglobulinemia, Gastric artery, embolization of, 148-150,
bleeding in, 36 155-156
Evacuation proctography, in pediatric Gastric atony, in Roux syndrome. See
patients, 630 Roux stasis (limb) syndrome.
Exercise, gastrointestinal bleeding in, Gastric banding, in morbid obesity, 349
Gastric bypass, in morbid obesity, 348-350
40-41
Gastric emptying. See also Dumping
syndrome.
after gastric surgery, nutritional aspects
Factors, clotting, measurement of, in of, 236-239
vitamin K status evaluation, 690 after pyloroplasty, 204
Familial adenomatous polyposis, bleeding after vagotomy, 204-206, 330-332, 334—
in, 111 337
Familial juvenile polyposis, 110 development of, 659-661
Familial pancreatitis. See Pancreatitis, in pediatric patients, 659-661
hereditary. liquid vs. solid, 330
Famotidine, in peptic ulcer disease, in modification of, pacing in, 394-395
pediatric patients, 107 prokinetic agents for, 315-325
Fat, absorption of, in short bowel normal physiology of, 330
syndrome, 406 Gastric reflexes, for food storage, 199-201
Fecal soiling, in pediatric patients. See Gastric sieving defects, after gastric
Encopresis. surgery, 237
Fetus, gastrointestinal motility Gastric wrapping, in morbid obesity, 349
development in. See Motility, in Gastrin, measurement of, in recurrent
pediatric patients, development of. peptic ulcer, 300-301
Fiber, dietary, for dumping syndrome, Gastritis, alkaline reflux. See Alkaline reflux
266-267 gastritis.
Fistula, after Nissen fundoplication, 376 Helicobacter pylori in, 709-711
aortoenteric, bleeding in, 167-168, 170- Gastroduodenostomy, loop syndromes
172 after, 224-225
FK506, after small intestine transplanta- Gastroesophageal reflux. See Reflux,
tion, 414 gastroesophageal.
776 CUMULATIVE INDEX 1994
Gastrogastrostomy, in morbid obesity, autoimmune, 764
348-349 in Epstein-Barr virus infection, 763—
Gastrointestinal motility. See Motility. 764
Gastrointestinal pacing. See Pacing, in liver transplantation, 764-765
gastrointestinal. viral, 753-763
Gastrojejunostomy, Billroth II. See Billroth non-A, non-B, blood-borne. See Hepatitis
II procedure. Cc.
Roux-en-Y, historical background of, water-borne. See Hepatitis E.
327-328 viral. See specific disease, e.g., Hepatitis
in dumping syndrome, 271-272 B; Viral hepatitis.
in recurrent peptic ulcer, 307-308 Hepatitis A, clinical features of, 754-755
postsurgical syndromes in. See Roux diagnosis of, historical overview of, 458
stasis (limb) syndrome. in pediatric patients, 754
Gastroparesis, in Roux syndrome. See molecular, 490-491
Roux stasis (limb) syndrome. serologic, 460-463
Gastroplasty, in morbid obesity, 348-349 epidemiology of, 437-441, 754
Gastrostomy, in small intestine in autoimmune hepatitis, 553
transplantation, 731 in pediatric patients, 754-755
Glomerulonephritis, hepatitis C in, 433 prevention of, 440-441, 755
Graft-versus-host disease, after small transmission of, 438-440
intestine transplantation, 738 treatment of, 755
Granulocyte-macrophage colony- vaccines for, 440-441, 755
stimulating factor, in hepatitis B, 758 antibodies induced by, determination
Guaiac test, for occult bleeding, 55 of, 462-463
Hepatitis A virus, antibodies to,
determination of, 459-463
vaccine-induced, 462-463
Hamartomatous polyp syndromes, molecular biologic features of, 480-481
bleeding in, 109-111 morphology of, 754
Heartburn, postoperative, 220-223 Hepatitis B, acute, diagnosis of, 463-464
recurrent, after antireflux surgery, 378- acute nonfulminant, viral mutation in,
379 507-508
Helicobacter pylori infection, alkaline reflux antigens of, determination of, 459-460
gastritis and, 286 vs. viral serum titer, 442
in pediatric patients, 107-108. See also asymptomatic, mutant virus in, 466
under Peptic ulcer disease, in pediatric carriers of, diagnosis of, 464-465
patients. family vaccination recommendations,
without peptic ulcer disease, 710-711 532
Hemangioma, in pediatric patients, 97-98 chronic, diagnosis of, 464465
small intestinal, 76 treatment of, interferon in, 574, 591-
Hemicolectomy, in diverticulosis, 18 592
in vascular ectasia, 9-10, 18 viral mutation in, 508-510
Hemobilia, in pediatric patients, 113 clinical features of, in pediatric patients,
radiologic management of, 170, 173 757
Hemoccult test, 55, 60 diagnosis of, historical overview of, 458
Hemolytic-uremic syndrome, bleeding in, in pediatric patients, 756
104-105 molecular, 486-487, 491-493
in enterohemorrhagic Escherichia coli in- serologic, 463-467
fection, 641-642 DNA of, determination of, 491-493
HemoQuant test, in occult blood detection, epidemiology of, 441-445
57 familial clustering and, 528
Hemorrhage. See Bleeding. in adopted Asian children, 529
Hemorrhagic colitis, enterohemorrhagic in Asian Americans, 524-530
Escherichia coli in, 641-642 in immunocompromised persons, 517
Henoch-Schénlein purpura, bleeding in, in neonates, 526-528
34, 103-104 in pediatric patients, 756
Hepatitis, autoimmune. See Autoimmune in pregnancy, in Asian Americans,
hepatitis. 525-526
cryptogenic, 551 fulminant, viral mutation in, 510-511
in pediatric patients, 753-767 hepatitis C association with, 494
CUMULATIVE INDEX 1994 777
hepatitis delta association with, 450, 493, detection of, 464-465, 756
495 DNA of, clearance of, in treatment, 582,
hepatocellular carcinoma and, 434, 568- 586-588
570, 572 detection of, 489-490, 756
in Asian Americans, 523-536 genomic organization of, 499-501
epidemiology of, 524-530 immune response to, 501-502
prevention of, 530-533 molecular biologic features of, 480-482
treatment of, 533-534 variants of, 432, 499-514
in autoimmune hepatitis, 552-553, 555, asymptomatic infection in, 466
557-558, 560 core, 511
in HIV infection, 518 detection of, 466, 492
in immunocompromise, 515-521 envelope, 502-507
in pediatric patients, 756-759 precore, 507-511
natural history of, in HIV infection, 519 X gene, 512
pathophysiology of, 431-432 Hepatitis C, acute, diagnosis of, 469-470
prevention of, 445 chronic, diagnosis of, 470
in Asian Americans, 530-533 treatment of, 603-613
in pediatric patients, 757-758 alternative agents in, 610
vaccines for, 757-758 goals of, 605
reactivated, diagnosis of, 465 interferon in, 605-610
transmission of, 442-445 pathogenesis and, 604-605
child-to-child, 527 clinical features of, in pediatric patients,
perinatal, 526-528 761
treatment of, 432, 581-601 diagnosis of, 432-433
alternative agents in, 594-596 branched DNA amplification in, 489-
antiviral agents in, combinations of, 490
593-594 historical overview of, 458
historical view of, 583-584 in pediatric patients, 760-761
for hepatocellular carcinoma preven-
molecular, 486, 493-495
tion, 574 serologic, 467-470
in Asian Americans, 533-534
disorders associated with, 433-434
in pediatric patients, 757-758
epidemiology of, 445-449
interferon in, 518, 574, 584-594
in immunocompromised persons, 517—
dose in, 590-591
518
in combination therapy, 593-594
in pediatric patients, 760
monitoring of, 590-591
hepatitis B association with, 494
nonresponders to, 596
hepatocellular carcinoma and, 434, 446,
response to, 584-589
side effects in, 589-590 570-572
liver biopsy in, 582-583 histology of, 538
serologic endpoints in, 581-582 histopathology of, 761
vaccines for, 445, 573, 758-759 in autoimmune hepatitis, 549-561
in Asian Americans, 531-533 in immunocompromise, 515-521
viral escape mutants and, 503-507 in pediatric patients, 760-761
window period of, 464, 467 natural history of, 603-604
Hepatitis B virus, antibodies to, in HIV infection, 519
determination of, 463-467 pathogenesis of, 604-605
molecular techniques in, 491 pathophysiology of, 431-432, 516-517
antigens of, 432 prevention of, 449, 761
core, detection of, 463-467, 756 relapse in, treatment of, 608
variants of, 511 transmission of, 432, 446-448
detection of, in hepatitis delta diagno- treatment of, 432, 603-613
sis, 471 alternative agents in, 610
envelope, clearance of, in treatment, for hepatocellular carcinoma preven-
582, 586-588 tion, 574
detection of, 464465 goals of, 605
variants of, 502-507 in pediatric patients, 761
immune response to, 501-502 interferon in, 605-610
precore, variants of, 507-511 pathogenesis and, 604-605
surface, clearance of, in treatment, relapse in, 608
582, 586 vaccines for, 573-574
778 CUMULATIVE INDEX 1994
Hepatitis C (Continued) risk factors for, 568
vs. autoimmune hepatitis, 557 screening for, 574-575
Hepatitis C virus, antibodies to, treatment of, 575-576
determination of, 459-460, 467-470 Hepatocytes, abnormalities of, in hepatitis
prevalence of, 446 E, 539-540
antigens of, detection of, 761 Hereditary disorders. See also Pancreatitis,
DNA of, detection of, 489-490 hereditary.
molecular biologic features of, 480-482 in pediatric patients, bleeding in, 109-
replication of, 604 112
variants of, 433 Hernia, hiatal. See Hiatal hernia.
Hepatitis delta, clinical features of, 760 retroanastomotic, after gastroduodenos-
diagnosis of, 759-760 tomy, 225
historical overview of, 458 Herpes virus infections, hepatitis in, in
molecular, 495-496 pediatric patients, 764
serologic, 471-472 Hiatal hernia, after antireflux surgery,
epidemiology of, 450, 759 219-220, 384-385
hepatitis B association with, 450, 493, postoperative, 222
495 Hill antireflux operation, results of,
hepatocellular carcinoma and, 572-573 373-374
in pediatric patients, 759-760 Hirschsprung’s disease, constipation in,
prevention of, 760 625-627, 629
treatment of, 760 embryology of, 657-658
Hepatitis delta virus, antibodies to, Hirschsprung’s-associated enterocolitis,
detection of, 471-472 99-100
antigen of, detection of, 471 Histamine,-receptor antagonists, in peptic
molecular biologic features of, 480-482 ulcer disease, in pediatric patients,
Hepatitis E, 537-546 716-719
clinical features of, 538-539, 763 recurrent, 301, 305-306
diagnosis of, 540 in short bowel syndrome, 406
historical overview of, 458 HIV infection. See Human immunodeficiency
in pediatric patients, 762 virus infection.
molecular, 496 Hollander test, in recurrent peptic ulcer,
serologic, 472-473 302
epidemiology of, 450-451, 537-538 Hookworm infection, occult bleeding in,
in pediatric patients, 761 59
in pediatric patients, 761-763 Human immunodeficiency virus infection,
in pregnancy, 538 bleeding in, 167-169
pathogenesis of, 540-541 hepatitis in, autoimmune, 553
pathology of, 539-540 in pediatric patients, 764
prevention of, 542-543, 763 viral, 518-519
transmission of, 450-451, 538 intussusception in, 39
treatment of, 763 Human leukocyte antigens, in
Hepatitis E virus, antibodies to, 541 autoimmune hepatitis, 548-549,
determination of, 472 557-558
antigens of, detection of, 472-473 Hybridization techniques, in viral hepatitis
characteristics of, 541-542 diagnosis, 484-487, 492, 494-495
molecular biologic features of, 480-481, Hydrocortisone, after small intestine
483 transplantation, 731
Hepatitis F, in pediatric patients, 763 25-Hydroxyvitamin D, measurement of, in
Hepatitis M/P, in pediatric patients, 763 cholestasis, 684-687
Hepatitis non-ABCDE, epidemiology of, Hypergastrinemia, recurrent peptic ulcer
437, 451 and, 300-301
Hepatocellular carcinoma, 567-579 Hyperlipidemia, vitamin E status
alcohol in, 573 evaluation in, 694, 698
epidemiology of, 567 Hypertension, portal. See Portal
in Asian Americans, 530 hypertension.
hepatitis B in, 434, 568-570, 572 Hypocalcemia, after gastric surgery,
hepatitis C in, 434, 446, 570-572 251-252
hepatitis delta in, 572-573 Hypochlorhydria, after gastric surgery,
prevention of, 573-574 245-246, 248